Biotechnology News

October 26, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Third quarter July - September 2012                                                                                                            Group net sales in the third quarter 2012 increased...

October 26, 2012

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: MEDIAN Technologies (Paris:ALMDT) (ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical...

October 25, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) will release its third quarter 2012 financial results on Wednesday, November 7, 2012, after the markets close. The announcement will be followed by a live webcast at 5:00...

October 25, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tobira receives key patent covering cenicriviroc family of compounds.

October 25, 2012

FRISCO, Texas--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB), today announced results for its third quarter ended September 28, 2012: Sales increased 22% over the prior year to $161.3 million and included 8% organic constant currency growth, as...

October 25, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the third quarter ended September 30, 2012. The Company...

October 25, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (12:30 p.m. GMT) on Thursday, November 1, 2012, to discuss the company’s financial results for the second quarter of fiscal 2013. Management will...

October 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, will present at 3 upcoming conferences.

October 25, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Image-Pro Premier image processing and analysis software now supports Surveyor Workspace mosaic format (.sws) image files acquired with Objective Imaging Surveyor Turboscan .sws Mosaic Files.

October 25, 2012

CANTON, Mass.--(BUSINESS WIRE)--EquipNet Auctions has been selected by Myrexis, Inc. to conduct a global webcast auction as a result of the company’s decision to suspend development activity on all its preclinical and clinical programs in...

October 25, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Southern Research wins contract continuation with Black & Veatch to work in Ukraine program.

October 25, 2012

NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 22-cent fourth-quarter 2012 dividend on the company’s common stock, payable December 4, 2012, to shareholders of record at the close of business on...

October 25, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN) Announces Release Dates for 2012 Third Quarter Results and Conference Call

October 25, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS), the genome engineering specialist, announces that it has signed two exclusive license agreements with the Iowa State University that grant Cellectis the worldwide right to use...

October 25, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Geomagic is showcasing innovative digitally designed facial prostheses, implants and surgical guides made with its software at this week’s International Congress on Maxillofacial Rehabilitation.

October 25, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Results from the St. Jude Medical RESPECT trial offer compelling evidence for PFO closure with the AMPLATZER PFO Occluder over conventional medical management alone.

October 25, 2012

BURR RIDGE, Ill.--(BUSINESS WIRE)--Integrated Project Management Company (IPM) named among top 25 small workplaces in the nation.

October 25, 2012

ATLANTA--(BUSINESS WIRE)--UPS (NYSE: UPS) today announced a significant expansion of its global healthcare distribution facility network in the Asia Pacific region with the opening of three new state-of-the-art facilities in Hangzhou, China,...

October 25, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed oncologists expect to take a more cautious approach toward prescribing...

October 25, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, has been inducted into the distinguished World...

October 25, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The merger and acquisition market for the health care industry posted slight declines in transaction numbers in the third quarter of 2012 compared with the year-ago quarter.

October 25, 2012

SEATTLE--(BUSINESS WIRE)--Theraclone Sciences has initiated its Phase 2 viral challenge study of TCN-032, a broadly protective and fully human monoclonal antibody, for the treatment of influenza A. Results are expected 1H13.

October 25, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus appoints Chrystal Menard chief legal officer, effective December 3, 2012, succeeding Howard Ervin.

October 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information suggests that managed market groups benefit from carefully constructing narratives for every payer presentation.

October 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron's ACE-536 demonstrates ability to treat both the severe anemia and serious organ damage due to iron overload in a preclinical model of rare blood disorder, beta-thalassemia

October 25, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces reporting date and time for Q3 2012 financial results.

October 25, 2012

SAN ANTONIO, Texas--(BUSINESS WIRE)--GenSpera and the Clinical Trial Network of Texas initiate Phase II G-202 trial in liver cancer.

October 25, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the third quarter of 2012 as follows: Quarterly Highlights: Achieved quarterly...

October 25, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics Army-funded Oxycyte preclincal studies to establish the product's safety profile is well underway and results are starting to come in.

October 25, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics has completed target enrollment of its second Phase 3 clinical trial of dalbavancin, under investigation for the treatment of ABSSSI caused by susceptible gram-positive bacteria.

October 25, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported total revenue of $1,419 million for the third quarter of 2012, a 14 percent increase from the same period in 2011. Adjusted (Non-GAAP) net income for the third quarter of...

October 25, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori announces that two investigator sponsored studies using their cell therapy have been approved at Kanazawa University in Japan. The trials are for ischemic heart failure & cirrhosis of the liver

October 25, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's third quarter 2012 financial results on Thursday, November 8, at 9:...

October 25, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced third quarter 2012 financial results, delivering revenue growth of 6 percent to $1.4 billion and non-GAAP diluted Earnings Per Share (EPS) growth of 19 percent. Third...

October 25, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Announces Enrollment Completion of DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold. Successful Live Case follow-up at TCT 2012. 1 yr MSCT Follow-up for DESolve FIM.

October 25, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and...

October 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Licensee Sanofi to Continue Prednisporin Development Under a Third-Party Sublicense

October 25, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories Inc. (Nasdaq: CBRX) (the “Company”) received a letter on October 24, 2012, from the Nasdaq Stock Market indicating that the Company no longer meets the minimum bid price requirement for...

October 25, 2012

--(BUSINESS WIRE)--Sanovas, Inc.:   WHO: Dr. Stephen C. Schimpff, physician, educator, scientist, hospital CEO, cancer researcher and author   Students, researchers, consumers, medical professionals, health care executives, patients and others...

October 25, 2012

MONTREAL--(BUSINESS WIRE)--Thrasos Therapeutics(TM) announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).

October 25, 2012

PARIS--(BUSINESS WIRE)--Each year the American Association for the Advancement of Science, which publishes the prestigious journals Science and Science Translational Medicine, the Karolinska institute in Stockholm, the DMMGF foundation and the...

October 25, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Regulatory News:  Novartis (SIX: NOVN) (NYSE:NVS): Key figures         Q3 2012       Q3 2011       % change       9M 2012       9M 2011       % change         USD m       USD m       USD       cc       USD m...

October 24, 2012

TORRANCE, Calif.--(BUSINESS WIRE)--On Nov 16-17, Phenomenex will hand pack 150,000 meals to feed starving children in the developing world through a partnership with Feed My Starving Children. All are invited to join and volunteer.

October 24, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Credit Suisse 21st Annual Healthcare Conference on Wednesday, November 14, at 9:30 a.m. (CT). The live webcast of Baxter’s...

October 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2012. This dividend is payable on February 8, 2013, to all...

October 24, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2012. Revenues for the third quarter were $0.4 million, compared to $0.4 million for...

October 24, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

October 24, 2012

MONTREAL--(BUSINESS WIRE)--Clinical studies have shown that an investigational new drug, pomalidomide, has demonstrated overall survival in a clinical trial of myeloma patients who had undergone multiple prior treatments.

October 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nearly half of surveyed companies report coordinating through globally centralized market research groups.